SUBSCRIBE
SUBSCRIBE

Prometheus Biosciences

NEWS
Prometheus Biosciences was acquired by Merck in June 2023.
Courtesy of John Smith/VIEWpress
Deals
Longboard, Prometheus Hit the Market with Hopes of Raising Over $250 Million Combined
The two pharmaceutical companies are going public and anticipate raising more than $250 million to advance research and development programs and support their business initiatives.
March 12, 2021
 · 
2 min read
 · 
Alex Keown
BioCapital
Artificial Organs for Biopharma Research and More
There has been recent coverage of 3D bioprinting and how it has the potential to create a brave new world of printed organs to be used in biopharma research and maybe someday to even be used in organ transplants.
July 1, 2018
 · 
4 min read
 · 
Mark Terry
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
IN THE PRESS
Business
Prometheus Biosciences Reports Third Quarter 2022 Financial Results and Highlights Recent Corporate Progress
November 9, 2022
 · 
8 min read
Biotech Beach
Prometheus Biosciences to Participate at November 2022 Healthcare Conferences
November 1, 2022
 · 
2 min read
Drug Development
Prometheus Biosciences Receives FDA Clearance of IND Application for its Second Precision Program, PRA052
October 3, 2022
 · 
5 min read
Biotech Beach
Prometheus Biosciences to Participate at September Healthcare Conferences
August 31, 2022
 · 
2 min read
Business
Prometheus Biosciences Reports Second Quarter 2022 Financial Results and Highlights Recent Corporate Progress
August 11, 2022
 · 
9 min read
Biotech Beach
Prometheus Biosciences to Host a Virtual R&D Day for Analysts and Investors on July 26, 2022
July 18, 2022
 · 
5 min read
Drug Development
Prometheus Biosciences Completes Enrollment of the ARTEMIS-UC Cohort 1 Phase 2 Study in Ulcerative Colitis
July 18, 2022
 · 
6 min read
Biotech Beach
Prometheus Biosciences Provides Enrollment Update in APOLLO-CD and ARTEMIS-UC Global Phase 2 Studies
June 8, 2022
 · 
8 min read
Biotech Beach
Prometheus Biosciences to Participate at the Jefferies Healthcare Conference
May 26, 2022
 · 
1 min read
Business
Prometheus Biosciences Reports First Quarter 2022 Financial Results and Highlights Recent Corporate Progress
May 12, 2022
 · 
10 min read
Load More